© 1990 British Society for Rheumatology
other |
IMMUNOGENETICS OF POLYMYALGIA RHEUMATICA
Molecular Immunogenetics and Rheumatology Units, Division of Medicine, UMDS Guy's Hospital, London
*Department of Rheumatology St Peters Hospital, Chertsey, Surrey
Correspondence to:
Correspondence to Dr K. Welsh, Molecular Immunogenetics, 18th Floor Tower, Guy's Hospital, London SE1 9RT
Evidence suggests that polymyalgia rheumatica (PMR) may be an immune-mediated disease. Therefore, the role of HLA class II genes, the switch region of immunoglobulin µ and
heavy chain as well as the T-cell receptor (TcR) genes were investigated by Southern blot analysis. The frequency of DR4 specificity was increased in PMR (67.4% versus 30.3%; P = 0.00017). No association was found with the DQA and DQB genes, the switch region of immunoglobulin µ and
1 heavy chain genes, and the TcR a, B and y genes. This study suggests that HLA-DR4 is an important susceptibility factor for PMR. Further studies are needed to elucidate the role of Ig and TcR genes
KEY WORDS: HLA, Immunoglobulin heavy chain genes, T-cell receptor genes, Southern blot
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Dudler, J.-C. Gerster, and A. So Polyarthritis and pitting oedema Ann Rheum Dis, March 1, 1999; 58(3): 142 - 147. [Full Text] |
||||
